StockWatch: Insilico Projects Profit, Revenue Leaps as AI-Developed Lead Candidate Moves to Phase III
Alex Zhavoronkov, PhD, Insilico Medicine founder and CEO, at the company’s robotics lab in Suzhou, China. The artificial…
Evogene advances ChemPass AI milestone with Google Cloud
Integration of agentic computational systems enables the early-stage definition of key clinical and biological success criteria, accelerating discovery…